1. Home
  2. GROW vs CGTX Comparison

GROW vs CGTX Comparison

Compare GROW & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GROW
  • CGTX
  • Stock Information
  • Founded
  • GROW 1968
  • CGTX 2007
  • Country
  • GROW United States
  • CGTX United States
  • Employees
  • GROW N/A
  • CGTX N/A
  • Industry
  • GROW Investment Managers
  • CGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GROW Finance
  • CGTX Health Care
  • Exchange
  • GROW Nasdaq
  • CGTX Nasdaq
  • Market Cap
  • GROW 32.9M
  • CGTX 30.0M
  • IPO Year
  • GROW N/A
  • CGTX 2021
  • Fundamental
  • Price
  • GROW $2.44
  • CGTX $0.65
  • Analyst Decision
  • GROW
  • CGTX Strong Buy
  • Analyst Count
  • GROW 0
  • CGTX 6
  • Target Price
  • GROW N/A
  • CGTX $8.30
  • AVG Volume (30 Days)
  • GROW 27.3K
  • CGTX 1.0M
  • Earning Date
  • GROW 02-14-2025
  • CGTX 03-25-2025
  • Dividend Yield
  • GROW 3.63%
  • CGTX N/A
  • EPS Growth
  • GROW N/A
  • CGTX N/A
  • EPS
  • GROW 0.12
  • CGTX N/A
  • Revenue
  • GROW $10,008,000.00
  • CGTX N/A
  • Revenue This Year
  • GROW N/A
  • CGTX N/A
  • Revenue Next Year
  • GROW N/A
  • CGTX N/A
  • P/E Ratio
  • GROW $20.31
  • CGTX N/A
  • Revenue Growth
  • GROW N/A
  • CGTX N/A
  • 52 Week Low
  • GROW $2.38
  • CGTX $0.34
  • 52 Week High
  • GROW $2.95
  • CGTX $2.95
  • Technical
  • Relative Strength Index (RSI)
  • GROW 51.41
  • CGTX 45.88
  • Support Level
  • GROW $2.42
  • CGTX $0.60
  • Resistance Level
  • GROW $2.50
  • CGTX $0.82
  • Average True Range (ATR)
  • GROW 0.04
  • CGTX 0.06
  • MACD
  • GROW 0.00
  • CGTX -0.02
  • Stochastic Oscillator
  • GROW 46.00
  • CGTX 27.63

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: